13,14-DIHYDRO-15-케토프로스타글란딘E2

13,14-dihydro-15-keto-PGE2

HCID 5280711
노트반응
부분 구조 검색유사 구조 찾기

기본 정보

CAS
363-23-5
표준 SMILES
CCCCCC(=O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O
InChIKey
CUJMXIQZWPZMNQ-XYYGWQPLSA-N
분자식
C20H32O5
평균 분자량
352.5 g/mol
단동위원소 질량
352.22497412

이름 및 식별자

우선 이름
13,14-dihydro-15-keto-PGE2
IUPAC
(Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
현지명
13,14-DIHYDRO-15-케토프로스타글란딘E2
영어명
13,14-DIHYDRO-15-KETO PROSTAGLANDIN E2
분자식
C20H32O5
분자량
352.47

이름 및 동의어

363-23-513,14-Dihydro-15-keto-PGE2PGEM15-Keto-13,14-dihydro-PGE215-keto-13,14-dihydroprostaglandin E2KH(2)PGE(2)9,15-dioxo-11R-hydroxy-5Z-prostenoic acidPGEM (13,14-dihydro-15-keto-PGE2)RefChem:437486prost-5-en-1-oic acid, 11-hydroxy-9,15-dioxo-, (5Z,11 alpha)-13,14-dihydro-15-keto Prostaglandin E213,14-Dihydro-15-ketoprostaglandin E2
이름 더 보기
13,14-DIHYDRO-15-케토프로스타글란딘E2CUJMXIQZWPZMNQ-XYYGWQPLSA-N15-keto-13,14-dihydroprostaglandine213,14-Dihydro-15-ketoprostaglandinE2 solution9,15-DIOXO-11ALPHA-HYDROXY-PROST-5Z-EN-1-OIC ACID(5Z)-11α-Hydroxy-9,15-dioxoprosta-5-ene-1-oic acid(5Z,11α)-11-Hydroxy-9,15-dioxoprost-5-en-1-oic acid
13,14-dihydro-15-oxo-prostaglandin E213,14-Dihydro-15-ketoPGE2(Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid13,14-dihydro-15-keto-Prostaglandin E2PGE2 13,14-dihydroProstaglandin EM(Z)-7-((1R,2R,3R)-3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl)hept-5-enoic acidDTXSID30869647

데이터베이스 식별자

CAS
363-23-5
PubChem CID
5280711
DTXSID
DTXSID30869647
ChEBI
CHEBI:15550
EC Number
633-709-4
Nikkaji
J264.983G

물성

구조 계산 물성

XLogP
2.4
극성 표면적
91.7 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
5
회전 가능 결합 수
13
무거운 원자 수
25

실험 및 물리화학적 성질

Physical DescriptionSolid
Collision Cross Section184.9 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Calculation: Single Field; Dataset: Oxylipins]

물리화학적 성질

끓는 점
538.1 · 538.1±45.0 °C(Predicted)
밀도
1.086 · 1.086±0.06 g/cm3(Predicted)
저장 조건
20 °C · −20°C
용해도
100 mg/mlDMSO: · DMF: >100 mg/mlDMSO: >100 mg/mlEthanol: >100 mg/mlPBS (pH 7.2): >5 mg/ml
물리적 상태
Liquid
산도 계수 (pKa)
4.75 · 4.75±0.10(Predicted)

안전 및 규제

GHS 분류

GHS Classification · 5건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]；H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]；H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]；H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H332 (100%): Harmful if inhaled [Warning Acute toxicity, inhalation]；H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (100%)；Acute Tox. 4 (100%)；Skin Irrit. 2 (100%)；Eye Irrit. 2 (100%)；Acute Tox. 4 (100%)；STOT SE 3 (100%)

안전 데이터

wgk
3
ridadr
UN 1231 3/PG 2
risk_code
11-20/21/22-36/37/38-67-66-36
hazard_code
F,Xn,Xi
safety_code
16-26-36

화학 및 산업

약리 정보

Cellular LocationsExtracellular；Membrane
응용 분야 · 2건

개요13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) is a metabolite of PGE2 and the primary PGE2 metabolite in plasma. It is formed from PGE2 via a 15-keto PGE2 intermediate by 15-oxo-PG Δ13 reductase. Unlike PGE2, 13,14-dihydro-15-keto PGE2 does not bind effectively to the PGE2 receptors EP2 and EP4 expressed in CHO cells (Kis = 12 and 57 μM, respectively) or induce adenylate cyclase activity in the same cells (EC50s = >18 and >38 μM, respectively). Levels of 13,14-dihydro-15-keto PGE2 are increased in the plasma of women in the third trimester of pregnancy and in women during and immediately after labor and delivery. Levels of 13,14-dihydro-15-keto PGE2 levels are decreased in tumor tissue compared to adjacent non-cancerous tissue isolated from patients with non-small cell lung cancer (NSCLC).

용도13,14-Dihydro-15-ketoPGE2 is a primary metabolite of PGE2 in plasma.

공급사10 곳

湖北科乐精细化工有限公司027-59101668 19945030958 · [email protected]
上海阿拉丁生化科技股份有限公司6206333 13167063860 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
成都标样生物科技有限公司028-81700200 13308200041 · [email protected]
上海宏叶生物科技有限公司400-9205774 400-920-5774 · [email protected]

추가 설명

정의ChEBI: The 13,14-dihydro derivative of 15-oxo-prostaglandin E2.

관련 반응

2건
반응 기록 만들기

화합물 노트

불러오는 중…